JPH10210982A - 新規なタンパク質 - Google Patents

新規なタンパク質

Info

Publication number
JPH10210982A
JPH10210982A JP9031505A JP3150597A JPH10210982A JP H10210982 A JPH10210982 A JP H10210982A JP 9031505 A JP9031505 A JP 9031505A JP 3150597 A JP3150597 A JP 3150597A JP H10210982 A JPH10210982 A JP H10210982A
Authority
JP
Japan
Prior art keywords
mmp
mouse
protein
salt
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9031505A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10210982A5 (https=
Inventor
Motoharu Seiki
元治 清木
Hiroshi Sato
博 佐藤
Takanori Aoki
隆則 青木
Shinichi Yoshida
真一 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Yakuhin Kogyo KK
Original Assignee
Fuji Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Kogyo KK filed Critical Fuji Yakuhin Kogyo KK
Priority to JP9031505A priority Critical patent/JPH10210982A/ja
Publication of JPH10210982A publication Critical patent/JPH10210982A/ja
Publication of JPH10210982A5 publication Critical patent/JPH10210982A5/ja
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP9031505A 1997-01-31 1997-01-31 新規なタンパク質 Pending JPH10210982A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9031505A JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9031505A JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Publications (2)

Publication Number Publication Date
JPH10210982A true JPH10210982A (ja) 1998-08-11
JPH10210982A5 JPH10210982A5 (https=) 2004-12-24

Family

ID=12333090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9031505A Pending JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Country Status (1)

Country Link
JP (1) JPH10210982A (https=)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018805A1 (fr) * 1998-09-29 2000-04-06 Kyowa Hakko Kogyo Co., Ltd. Nouveaux anticorps, medicaments les contenant et methodes de criblage de composes par utilisation desdits anticorps
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
CN102203293A (zh) * 2008-10-27 2011-09-28 奇亚根盖瑟斯堡股份有限公司 快速结果杂交捕获测定和系统
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US10208109B2 (en) 2005-11-30 2019-02-19 Abbvie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1118622A4 (en) * 1998-09-29 2002-10-30 Kyowa Hakko Kogyo Kk NEW ANTIBODIES, MEDICINAL PRODUCTS CONTAINING THEM AND METHODS FOR SCREENING COMPOUNDS USING THESE ANTIBODIES
WO2000018805A1 (fr) * 1998-09-29 2000-04-06 Kyowa Hakko Kogyo Co., Ltd. Nouveaux anticorps, medicaments les contenant et methodes de criblage de composes par utilisation desdits anticorps
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7196162B2 (en) 2001-08-16 2007-03-27 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US10464976B2 (en) 2003-01-31 2019-11-05 AbbVie Deutschland GmbH & Co. KG Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US9540432B2 (en) 2005-11-30 2017-01-10 AbbVie Deutschland GmbH & Co. KG Anti-Aβ globulomer 7C6 antibodies
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US10538581B2 (en) 2005-11-30 2020-01-21 Abbvie Inc. Anti-Aβ globulomer 4D10 antibodies
US10323084B2 (en) 2005-11-30 2019-06-18 Abbvie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US10208109B2 (en) 2005-11-30 2019-02-19 Abbvie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US9394360B2 (en) 2006-11-30 2016-07-19 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US9359430B2 (en) 2006-11-30 2016-06-07 Abbvie Inc. Abeta conformer selective anti-Abeta globulomer monoclonal antibodies
US9951125B2 (en) 2006-11-30 2018-04-24 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
CN102203293A (zh) * 2008-10-27 2011-09-28 奇亚根盖瑟斯堡股份有限公司 快速结果杂交捕获测定和系统
US9822171B2 (en) 2010-04-15 2017-11-21 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US10047121B2 (en) 2010-08-14 2018-08-14 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins

Similar Documents

Publication Publication Date Title
US6191255B1 (en) Protein and monoclonal antibody specific thereto
JP3837494B2 (ja) 可溶型ｒａｇｅタンパク質
JPH10210982A (ja) 新規なタンパク質
JP2003533174A (ja) 新規なポリペプチドおよびこのポリペプチドをコードする核酸
JP4488140B2 (ja) セリンプロテアーゼであるコリン
JP2000050885A (ja) カテプシンに対する抗体およびそれらの利用
JPH0987299A (ja) Ｍｍｐ−２活性化因子に特異的なモノクローナル抗体
JP2000270874A (ja) 新規な膜結合型メタロプロテアーゼ
JPH0984589A (ja) 新規なタンパク質
EA007273B1 (ru) Выделенный полипептид, связывающийся с каспазой -8, и способы его применения
JP2003321494A (ja) プロｍｍｐ−７の活性化調節方法
JP4171228B2 (ja) 可溶型ｒａｇｅ測定法
CA2350165C (en) Novel serine protease bssp6
US6806075B1 (en) Corin, a serine protease
JP2003000249A (ja) クローディンによるＭＴ−ＭＭＰｓを介したｐｒｏＭＭＰ−２活性化
US6998245B1 (en) Serine protease BSSP5
US6800473B1 (en) Human cathepsin L2 protein, gene encoding said protein and use thereof
US6908756B1 (en) Serine protease BSSP2
JP2004329040A (ja) ポリセラーゼ−ｉ及びその利用
US20050026255A1 (en) Corin, a serine protease
JP2000157263A (ja) 新規なヒトカテプシンｙタンパク質及びそれをコードす る遺伝子並びにそれらの利用
JP2006180813A (ja) アミノペプチダーゼｏおよびその利用
US7211425B2 (en) Serine protease BSSP4
JP2003180384A (ja) Ａｄａｍｔｓ−１５，−１６，−１７，−１８及び−１９
WO2000031277A1 (en) Novel serine proteases bssp4

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070508

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071009